HOOKIPA Pharma Inc (HOOK)
4.24
+0.05
(+1.19%)
USD |
NASDAQ |
Sep 27, 16:00
4.24
0.00 (0.00%)
After-Hours: 20:00
HOOKIPA Pharma SG&A Expense (Annual): 18.63M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 18.63M |
December 31, 2022 | 18.76M |
December 31, 2021 | 17.27M |
December 31, 2020 | 18.08M |
Date | Value |
---|---|
December 31, 2019 | 16.72M |
December 31, 2018 | 6.844M |
December 31, 2017 | 4.385M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
16.72M
Minimum
2019
18.76M
Maximum
2022
17.89M
Average
18.08M
Median
2020
SG&A Expense (Annual) Benchmarks
Arvinas Inc | 100.30M |
NovaBay Pharmaceuticals Inc | 12.83M |
Palatin Technologies Inc | 15.29M |
iBio Inc | 11.67M |
Theriva Biologics Inc | 7.12M |